Medicine Expenditure Trends in Côte d'Ivoire
Abstract
Background: Expenditure related to medicines has increased significantly in several countries. This study aimed to describe medicine expenditure trends at the Mutual Insurance Company for Civil Servers and Agents of the State of Côte d’Ivoire (MUGEFCI) between 2014 and 2018.
Methods: We conducted a retrospective analysis of the medicine expenditure of the MUGEFCI. Beneficiaries who used at least one drug reimbursed between 1st January 2014 and 31st December 2018 were included in the study. Expenditure was estimated on the basis of public pharmacy prices. They were described by ATC class and by age group.
Results: In 2014, the medicine expenditure was XOF 14.720 billion (approximately € 22.44 million), which increased by 63.21% in 2018. The medicine classes that incurred the highest expenditures were, for the first level (ATC main group), anti-infectives for systemic use (23.84%) and cardiovascular medicines (15.23%). Anti-parasitic products, insecticides and repellents (9.79%) and medicines for the alimentary tract and metabolism (9.67%) were also used. Total expenditure was most important for young adults aged 35-45 years.
Medicine Expenditure, ATC System, Africa, Mutual Insurance
Company, Retrospective AnalysisMedicine expenditures have increased significantly. The rational use of medicines and control of the expenditure they generate is a major challenge to guarantee access to medicines.